GPT and Hepatic steatosis: Despite slight decrease in body-weight (Figure 2) and fat composition (Figure 3), MH significantly lowered plasma TG and cholesterol levels (Figure 4), markedly ameliorated insulin resistance (Figure 6) and hepatic steatosis (Figure 5), along with decrease of liver weight, hepatic TG level (Figure 5(b)), and ALT activity (Figure 4(c)), and obviously deceased adipocyte size and amount of mast cells in adipose tissue (Figures 3(c) and 3(d)).